Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-16-005148
Filing Date
2016-03-17
Accepted
2016-03-17 18:07:33
Documents
2
Period of Report
2016-03-15

Document Format Files

Seq Description Document Type Size
1 form4-03172016_030325.html 4  
1 form4-03172016_030325.xml 4 3982
2 ex24-03172016_030325.htm EX-24 3230
  Complete submission text file 0001415889-16-005148.txt   8592
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NEUROGEN CORP 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address
DAVIS STEPHEN (Reporting) CIK: 0001131146 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 161513552